New Key Statistics Module, Z-Score and F-Score
OTCPK:DXNHF Key Ratios
Market Cap $ M | 279.28 |
Enterprise Value $ M | 287.35 |
P/E(ttm) | 40.81 |
PE Ratio without NRI | 36.19 |
Forward PE Ratio | 25.79 |
Price/Book | 1.42 |
Price/Sales | 1.92 |
Price/Free Cash Flow | 14.54 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 156.00 |
EPS (TTM) $ | 0.67 |
Beneish M-Score | -3.1 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 45.50 |
y-y EBITDA Growth Rate % | 6.60 |
EV-to-EBIT | 18.36 |
EV-to-EBITDA | 8.96 |
PEG | 0.80 |
Shares Outstanding M | 10.03 |
Net Margin (%) | 4.59 |
Operating Margin % | 8.91 |
Pre-tax Margin (%) | 6.88 |
Quick Ratio | 2.26 |
Current Ratio | 2.69 |
ROA % (ttm) | 2.11 |
ROE % (ttm) | 3.77 |
ROIC % (ttm) | 3.95 |
Dividend Yield % | -- |
Altman Z-Score | 1.95 |
DXNHF Number of Guru Trades
DXNHF Volume of Guru Trades
Gurus Latest Trades with OTCPK:DXNHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:DXNHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eurobio Scientific Insider Transactions
No Available Data
News about OTCPK:DXNHF
Total 0- 1